Most importantly, analysis of the Cav-1–P2Y2R protein-protein interaction domains may unveil promising targets for drug discovery and the development of treatment for conditions where both have been shown to play a role, such as neurodegenerative diseases [19,20], cancer [25], and brain injury [2,3,21,23,33]. This evidence concerns the gene P2RY2 and cancer.